- Earth Science Tech operates through diverse subsidiaries in the CBD space
- The company offers a wide range of CBD products, as well as its MSN-2 medical device
- ETST has varied distribution agreements in place to strengthen its foothold in the CBD marketplace
Earth Science Tech Inc. (OTCQB: ETST) is a biotechnology company operating in varied and vibrant market sectors, including hemp cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical-device research and development. Headquartered in Doral, Florida, the company functions by way of diverse, wholly owned subsidiaries centered on developing its role as a global leader in the CBD space. These subsidiaries are also expanding Earth Science Tech’s work in the pharmaceutical and medical-device sectors.
Earth Science Pharmaceutical Inc. is one of the company’s subsidiaries. Its emphasis is on becoming a worldwide leader in the development of low-cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for STIs (sexually transmitted infections and/or diseases) (http://cnw.fm/z4EiI). The first medical device offered by Earth Science Pharmaceutical is the MSN-2 Chlamydia Home Kit Screening, designed to detect STIs.
The company’s technology depends on the use of a modified panty liner (MSN-2) worn for four hours to collect a sample of human cells. The liner is then sent to a designated lab, where the cells are subsequently analyzed employing a proven and established process. Modified panty liners have less- strict transport criteria than urine or vaginal swabs. The company is advancing clinical trials of MSN-2 via a collaborative agreement with Laboratories BNK Canada (http://cnw.fm/6XjnO).
Another subsidiary of Earth Science Tech is Cannabis Therapeutics Inc. Cannabis Therapeutics is committed to become a global leader in cannabinoid research and development (R&D) for an extensive line of cannabinoid-based pharmaceuticals, nutraceuticals and other products and solutions. Its mission is to help change the health care landscape by introducing proprietary products made for the global pharmaceutical- and retail-consumer markets.
Cannabis Therapeutics has a provisional application patent for CBD and is invested in R&D to explore and harness the medicinal power of cannabidiol. The company is working to develop CBD-based drugs and nutraceutical products and is also working to integrate CBD molecules with existing generic drug molecules. Cannabis Therapeutics is concentrating on developing pioneering products that provide treatment options for patients and physicians.
Furthermore, Earth Science Tech has its Canna Inno Laboratories Inc. subsidiary. Earth Science Tech established this subsidiary in 2017 to carve out a position in the Canadian province of Québec, giving ETST inside access to the thriving Canadian CBD market. Canna Inno Laboratories provides ETST with access to government grants offered to innovators in the pharmaceutical industry; Canna Inno’s first grant has received approval (http://cnw.fm/1sOxH).
Overall, Earth Science Tech offers its unique product lineup in varied forms including liquids, tablets, capsules, soft gels, sprays, chewables, creams, whole herbs and powders. The company’s product family includes CBD oil for pets, flavored and infused CBD oils and a line of organic chocolate CBD products. The company’s CBD oil is 100 percent natural and organic and is manufactured using a supercritical CO2 liquid extraction process.
Earth Science Tech also has key distribution agreements in place to further the market reach of its products. This year, the company signed agreements to distribute CBD products via pharmacies, chiropractors, dispensaries, athletic clubs and clinics (http://cnw.fm/jF84w). ETST is advancing product placement in large chains, health-food stores and other establishments, and the agreements are for the distribution of a high-grade, full-spectrum cannabinoid line. Agreements are in place with CannaBiz and Desert Sun Distribution.
Moreover, Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to work on projects that scientifically support and advance the health care benefits of the company’s high-grade, hemp-CBD oil.
Earth Science Tech continues to focus on the new frontier involving the innovative integration of CBD with generic drug molecules. With a management team that has decades of invaluable experience in the nutraceutical, dietary supplement, and life sciences sectors, ETST offers investors an attractive opportunity in the emerging CBD space. Earth Science Tech remains dedicated to growing its product portfolio and customer base.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://cnw.fm/ETST
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
